Clinical Trials Directory

Trials / Unknown

UnknownNCT03034382

Morphine and/or Nalbuphine as Adjuvants in Ultrasound Guided Interscalene Block: for Shoulder Surgeries

Adjuvants to Ultrasonic Guided Interscalene Block In Arthroscopic Rotator Cuff Repair; Morphine and/or Nalbuphine

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

the aim of this study is to evaluate the duration of analgesia when either morphine or nalbuphine or both are used as adjuvants in sonar guided interscalene brachial plexus block for arthroscopic rotator cuff repair.

Conditions

Interventions

TypeNameDescription
DRUGMorphine5 mg morphine in 5 ml volume are injected perineurally as adjuvants for 10 ml of lidocaine + epinephrine 1:400,000 in ultrasound guided interscalene block
DRUGNalbuphine5 mg nalbuphine in 5 ml volume are injected perineurally as adjuvants for 10 ml of lidocaine + epinephrine 1:400,000 in ultrasound guided interscalene block
DRUGBupivacaine 0.5%10 ml of 1% lidocaine +1:400,000 epinephrine and 5 ml of bupivacaine 0.5% injected perineurally in interscalene block
DRUGLidocaine Hydrochloride 1% and epinephrine 1:400,00010 ml of 1% lidocaine and 1:400,000 epinephrine were injected perineurally in interscalene block

Timeline

Start date
2016-01-01
Primary completion
2017-05-01
Completion
2017-06-01
First posted
2017-01-27
Last updated
2017-05-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03034382. Inclusion in this directory is not an endorsement.